Celltrion | 068270 - 资产

金融业

KRW

KRW 768.81B

现金及等价物

KRW 56.79B

KRW 92.83B

KRW 481.57B

KRW 292.71B

KRW 160.58B

股息收益率

0.38

KRW 13.41B

KRW 19.64B

1.07K

EPS每股收益

KRW 1.35K

股本和储备

KRW 434.82B

KRW 39.29B

债务利息支出

KRW 19B

KRW 779.01M

KRW 411.27B

KRW 41786.32B

KRW 8.82B

KRW 119.22B

KRW 12.9B

普通股股本

KRW 229.65M

58.97

KRW 11.84B

KRW 1240B

销售和管理费用

KRW 9.32B

KRW 126B

贸易债权人

KRW 88.58B

应收帐款人

KRW 2009.82B

	资产	更改		日
Akebia Therapeutics	USD 349.66M		12.86M	2026-06
Alaunos Therapeutics	USD 1.88M		1.08M	2026-03
Avita Medical	AUD 56.39M		1.74M	2025-12
Celltrion	KRW 768.81B		9.37B	2026-03
Dianthus Therapeutics	USD 1.21B		33.61M	2026-06
Ionis Pharmaceuticals	USD 2.99B		455.5M	2026-06
IQVIA Holdings	USD 29.88B		206M	2026-06
Moderna	USD 10.96B		527M	2026-06
Organon & Co	USD 13.18B		182M	2026-06
Revvity	USD 12.05B		49.24M	2026-06
Tectonic Therapeutic	USD 246.58M		14.46M	2026-03
Viatris	USD 35.04B		1.79B	2026-06
Xeris Pharmaceuticals	USD 411.9M		19.89M	2026-06